Therapeutic preparations and physicians' samples: excise duty applies, but valuation must exclude profit not earned on free distribution.

Tinctures, extracts and spirit preparations used therapeutically were treated as "medicinal preparations" under Section 2(g) of the Medicinal and Toilet Preparations (Excise Duties) Act, 1955, because the statutory definition covered substances used as remedies for treatment, mitigation or prevention of disease; the challenge to duty on that basis failed. Physicians' samples distributed free of cost were not exempt from excise duty because the Act contained no such exemption, but assessable value had to reflect only the manufacturing element. Manufacturing cost and manufacturing profit were relevant, while post-manufacturing elements and profit not actually earned on free samples were excluded; refund claims were remitted for reconsideration to that extent.

---

---

Issues: (i) Whether tinctures, extracts and spirit preparations used as ingredients in the manufacture of proprietary medicines were "medicinal preparations" within the meaning of Section 2(g) of the Medicinal and Toilet Preparations (Excise Duties) Act, 1955; and (ii) whether excise duty could be levied on physicians' samples distributed free of cost, and if so, how their value was to be determined.

Issue (i): Whether tinctures, extracts and spirit preparations used as ingredients in the manufacture of proprietary medicines were "medicinal preparations" within the meaning of Section 2(g) of the Medicinal and Toilet Preparations (Excise Duties) Act, 1955.

Analysis: The statutory definition extended to all drugs used as remedies or prescriptions for internal or external use and to substances intended for treatment, mitigation or prevention of disease in human beings or animals. On the materials relied upon, the products in question were recognised medicinal substances in their own right and were used as remedies for therapeutic purposes, not merely as non-medicinal ingredients lacking independent medicinal character.

Conclusion: The products were held to fall within the definition of "medicinal preparation" and the challenge to levy of excise duty on that ground failed, against the assessee.

Issue (ii): Whether excise duty could be levied on physicians' samples distributed free of cost, and if so, how their value was to be determined.

Analysis: The Act contained no exemption for physicians' samples. The valuation rule attracted the principles governing assessment on value, and the relevant measure could not ignore the manufacturing element merely because the goods were not sold in the ordinary market. In computing value for duty, manufacturing cost and manufacturing profit were the relevant components, while post-manufacturing elements were not to be loaded. Free distribution did not eliminate liability, but profit not actually earned on such samples could not form part of the assessable value.

Conclusion: Duty was held leviable on physicians' samples, but the manufacturing profit relatable to free samples had to be excluded in determining value, in favour of the assessee in part.

Final Conclusion: The appeal succeeded only to the limited extent of securing exclusion of manufacturing profit in the valuation of physicians' samples and remitted consideration of refund claims, while the challenge to duty on the medicinal products themselves was rejected.

Ratio Decidendi: A substance used therapeutically as a remedy may itself be a medicinal preparation even if it also serves as an ingredient in another medicine, and physicians' samples remain dutiable where the statute provides no exemption, though assessable value must be confined to the manufacturing element and exclude profit not actually earned on free distribution.

---